Amgen | Liquidités



Cash And Equivalent Changement Date
AbbVie USD 5.52B 1.73B 2024-12
Agios Pharmaceuticals USD 76.25M 177.48M 2024-12
ALKERMES USD 291.15M 636.63M 2024-12
Amgen USD 11.97B 2.96B 2024-12
Biogen USD 2.38B 675.8M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Eli Lilly USD 3.27B 100.6M 2024-12
Exelixis USD 217.37M 40.97M 2025-01
Genmab DKK 9.86B 3.52B 2024-12
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
J&J USD 6.12B 1.28B 2024-12
Merck USD 13.24B 1.35B 2024-12
Moderna USD 1.93B 283M 2024-12
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Novartis USD 11.46B 2.15B 2024-12
Pfizer USD 1.04B 49M 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Takeda JPY 494.13B 364.89B 2024-12
Teva Pharmaceutical Industries USD 3.3B 19M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Amgen Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.